nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An overview of the clinical experience with hydroxyurea
|
Donehower, Ross C. |
|
1992 |
19 |
3S9 |
p. 11-20 10 p. |
artikel |
2 |
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia
|
Kolitz, Jonathan E. |
|
1992 |
19 |
3S9 |
p. 27-33 7 p. |
artikel |
3 |
CME test
|
|
|
1992 |
19 |
3S9 |
p. 117-128 12 p. |
artikel |
4 |
Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: Summary of an in vitro model and initial clinical pilot experience
|
Albain, Kathy S. |
|
1992 |
19 |
3S9 |
p. 102-109 8 p. |
artikel |
5 |
Enhancement of the loss of multiple drug resistance by hydroxyurea
|
Christen, Randolph D. |
|
1992 |
19 |
3S9 |
p. 94-101 8 p. |
artikel |
6 |
Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix
|
Stehman, Frederick B. |
|
1992 |
19 |
3S9 |
p. 48-52 5 p. |
artikel |
7 |
High-dose hydroxyurea in autologous bone marrow transplantation: A promising “new” agent
|
Vaughan, William P. |
|
1992 |
19 |
3S9 |
p. 110-116 7 p. |
artikel |
8 |
Hydroxyurea and erythropoietin therapy in sickle cell anemia
|
Goldberg, Mark A. |
|
1992 |
19 |
3S9 |
p. 74-83 10 p. |
artikel |
9 |
Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease
|
Dover, George J. |
|
1992 |
19 |
3S9 |
p. 61-66 6 p. |
artikel |
10 |
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer
|
Vokes, Everett E. |
|
1992 |
19 |
3S9 |
p. 53-60 8 p. |
artikel |
11 |
Laboratory and clinical studies of biochemical modulation by hydroxyurea
|
Schilsky, Richard L. |
|
1992 |
19 |
3S9 |
p. 84-89 6 p. |
artikel |
12 |
Mechanism of action of hydroxyurea
|
Yarbro, John W. |
|
1992 |
19 |
3S9 |
p. 1-10 10 p. |
artikel |
13 |
Radiosensitization and cell kinetics: Clinical implications for S-phase-specific radiosensitizers
|
Kinsella, Timothy J. |
|
1992 |
19 |
3S9 |
p. 41-47 7 p. |
artikel |
14 |
Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: The National Institutes of Health experience
|
Rodgers, Griffin P. |
|
1992 |
19 |
3S9 |
p. 67-73 7 p. |
artikel |
15 |
The evolution of hydroxyurea therapy in chronic myelogenous leukemia
|
Kennedy, B.J. |
|
1992 |
19 |
3S9 |
p. 21-26 6 p. |
artikel |
16 |
The place of hydroxyurea in the treatment of primary brain tumors
|
Levin, Victor A. |
|
1992 |
19 |
3S9 |
p. 34-40 7 p. |
artikel |
17 |
Treatment of colon cancer based on biochemical modulation of fluoropyrimidines by hydroxyurea
|
Muggia, Franco M. |
|
1992 |
19 |
3S9 |
p. 90-93 4 p. |
artikel |